ArticleNature cancer2023

Targeting T cell checkpoints 41BB and LAG3 and myeloid cell CXCR1/CXCR2 results in antitumor immunity and durable response in pancreatic cancer.

Pat Gulhati et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.